These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24868350)
1. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level. Shin HW; Sohn YH J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350 [TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study. Anamnart C; Kitjarak R J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189 [TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
5. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease. Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010 [TBL] [Abstract][Full Text] [Related]
6. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis. Dong B; Wu R Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593 [TBL] [Abstract][Full Text] [Related]
7. Association between the risk and severity of Parkinson's disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis. Quan Y; Xu J; Xu Q; Guo Z; Ou R; Shang H; Wei Q Front Aging Neurosci; 2023; 15():1254824. PubMed ID: 37941998 [TBL] [Abstract][Full Text] [Related]
8. Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson's Disease: A Cross-Sectional Study. Ouyang Q; Xu L; Zhang Y; Huang L; Li L; Yu M Neuropsychiatr Dis Treat; 2024; 20():913-921. PubMed ID: 38707522 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson's Disease. Kocer B; Guven H; Conkbayir I; Comoglu SS; Delibas S Parkinsons Dis; 2016; 2016():1589747. PubMed ID: 27642535 [TBL] [Abstract][Full Text] [Related]
14. The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism. Zhang L; Yan J; Xu Y; Long L; Zhu C; Chen X; Jiang Y; Yang L; Bian L; Wang Q PLoS One; 2011 Apr; 6(4):e19333. PubMed ID: 21556377 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893 [TBL] [Abstract][Full Text] [Related]
17. Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis. Liu Y; Gou M; Guo X J Integr Neurosci; 2023 Aug; 22(5):115. PubMed ID: 37735121 [TBL] [Abstract][Full Text] [Related]